Minimal important differences of EORTC QLQ-C30 for metastatic breast cancer patients: Results from a randomized clinical trial

PURPOSE: To establish minimal important differences (MIDs) for the European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 (EORTC QLQ-C30) in patients with metastatic breast cancer. METHODS: The dataset was obtained from the SELECT BC-CONFIRM randomized clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawahara, Takuya, Taira, Naruto, Shiroiwa, Takeru, Hagiwara, Yasuhiro, Fukuda, Takashi, Uemura, Yukari, Mukai, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098551/
https://www.ncbi.nlm.nih.gov/pubmed/34982354
http://dx.doi.org/10.1007/s11136-021-03074-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098551/
https://www.ncbi.nlm.nih.gov/pubmed/34982354
http://dx.doi.org/10.1007/s11136-021-03074-y

Ejemplares similares